Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. (Q42251011)

19 October 2017

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. (English)

1 reference

progressive multifocal leukoencephalopathy

19 October 2017

0 references

1 reference

J L Casado

1

1 reference

19 October 2017

I Corral

2

1 reference

19 October 2017

J García

3

1 reference

19 October 2017

J Martinez-San Millán

4

1 reference

19 October 2017

E Navas

5

1 reference

19 October 2017

A Moreno

6

1 reference

19 October 2017

S Moreno

7

1 reference

19 October 2017

16 August 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

19 October 2017

1 reference

19 October 2017

33

1 reference

19 October 2017

2

1 reference

19 October 2017

179-187

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-013-1941-6

19 October 2017

0 references

cites work

Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Management of late-presenting patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

The Effect of Highly Active Antiretroviral Therapy-Induced Immune Reconstitution on Development and Outcome of Progressive Multifocal Leukoencephalopathy: Study of 43 Cases with Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Differential improvement in survival among patients with AIDS after the introduction of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Epidemiological evidence and molecular basis of interactions between HIV and JC virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Diagnosis of central nervous system complications in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10096-013-1941-6

21 January 2018

12 December 2020

Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Neurologic complications of HIV disease and their treatment

1 reference

12 December 2020

Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

10.1007/S10096-013-1941-6

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference